Treatment as Prevention in Africa workshop
April 30 – May 3, 2014 Gaborone, Botswana
For more information please visit TasP webpage
TanZamBo-BHP TESA Training Workshop
on Laboratory Monitoring of HIV-1 Drug Resistance
Botswana-Harvard AIDS Institute Partnership
18th-21st June, 2012
Regional Course: The Botswana-Harvard AIDS Institute Partnership (BHP) will hold a course in Laboratory monitoring of HIV-1 Drug Resistance at the Botswana Harvard Reference Laboratory, Princess Marina Hospital grounds, Gaborone. The goals of the workshop are to provide participants with:
1) Insight into successes and associated challenges of HIV‐1 treatment
2) In depth understanding of the current laboratory techniques for detection and monitoring HIV- 1 drug resistance
3) Hands‐ on training on molecular techniques for determination of HIV-1 drug resistance
4) Hands-on computer training on analysis and interpretation of HIV-1 sequence data
The workshop will be moderated by selected speakers and instructors with vast experience in the area of HIV‐1 drug resistance. Practical hands-on sessions will be conducted within BHP, which is equipped with state-of-the-art laboratory facilities.
TanZamBo PI: Dr. Rosemary M Musonda (Botswana Harvard AIDS Institute Partnership)
Course Coordinators: Drs. Simani Gaseitsiwe, Daniel Ochiel (BHP-Harvard School of Public Health), Chanda Mulenga (TDRC, Ndola, Zambia) and Balthaza Nyombi (KCMC, Tanzania)
Who should attend: The workshop is tailored for participants with limited experience in HIV Drug resistance genotyping but who after training will have access to HIV drug resistance genotyping facilities in their respective countries.
HIV Neutralizing Antibody Assays Workshop Programme
Sponsor: EDCTP Senior Fellowship Grant
05–16 September 2011
The workshop is for applicants selected from the southern African region who are planning the implementation of HIV antibody neutralizing techniques in their projects and Institutes. The workshop will inform participants about advances made so far in application of the techniques, guidelines and procedures. The main objectives include;
- Training participants the importance of neutralizing antibody work,
- Assist participants in developing approaches to constructing their own neutralizing project work,
- Training participants in proper assay planning and management,
- Providing participants with information about the assay design and data manipulation,
- Informing participants about important role of the assays in evaluation of correlates of transmission blocking immunity,
- Informing participants of research integrity and consequences of unplanned culture procedures and the involvement of the requirement of a rigorous schedule when undertaking the assays.
For more detailed information, download a pdf.
BHP HIV Lecture Series 2011
Virology, Immunology, Pathology and Epidemiology of HIV
Lecture 1: Origins, Evolution & Variants, Bethan McDonald, PhD
Lecture 2: Genome, Structure & Life Cycle, Bethan McDonald, PhD
Lecture 3: HIV Accesory Genes: Accessories to the Crime, Laura Cheney, PhD
Lecture 4: Immunology of HIV, Takafira Mduluza, PhD
Lecture 5: Immunology of HIV, Takafira Mduluza, PhD
Lecture 6: Immunology of HIV, Simani Gaseitsiwe, PhD
Lecture 7: The National Programme, Barthemely Ndjibu, MD
Lecture 8: HIV & Aging, Hermann Bussmann, MD, MPH
Lecture 9: HIV & Family Planning, Barthemely Ndjibu, MD
Lecture 10: Global & Local Epidemiology, Lillian Okui, MD, MPH
Lecture 11: Careers & Opportunities, Rosemary Musonda, PhD – Chair
Over 4,000 leading researchers and clinicians from around the world convened in Boston for the 18th Conference on Retroviruses and Opportunistic Infections (CROI).
Feb 27–Mar 2, 2011
Prevention and Control of the HIV Epidemic in Botswana:
Surveillance, Modeling and Implementation of Interventions
June 12–15, 2008
The conference brought together epidemiologists, virologists, biostatisticians, behavioral scientists, clinicians, expert from the Botswana Ministry of Health and others. The conference was designed to stimulate discussion about HIV surveillance and prevention strategies. Read more.